11-14644484-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000922.4(PDE3B):āc.409A>Gā(p.Thr137Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,610,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_000922.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDE3B | ENST00000282096.9 | c.409A>G | p.Thr137Ala | missense_variant | 1/16 | 1 | NM_000922.4 | ENSP00000282096.4 | ||
PDE3B | ENST00000455098.2 | c.409A>G | p.Thr137Ala | missense_variant | 1/16 | 1 | ENSP00000388644.2 | |||
PDE3B | ENST00000534317.1 | n.225A>G | non_coding_transcript_exon_variant | 1/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000532 AC: 8AN: 150462Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000417 AC: 10AN: 240014Hom.: 0 AF XY: 0.0000229 AC XY: 3AN XY: 130916
GnomAD4 exome AF: 0.000119 AC: 174AN: 1460402Hom.: 0 Cov.: 33 AF XY: 0.000113 AC XY: 82AN XY: 726486
GnomAD4 genome AF: 0.0000532 AC: 8AN: 150462Hom.: 0 Cov.: 31 AF XY: 0.0000544 AC XY: 4AN XY: 73470
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2023 | The c.409A>G (p.T137A) alteration is located in exon 1 (coding exon 1) of the PDE3B gene. This alteration results from a A to G substitution at nucleotide position 409, causing the threonine (T) at amino acid position 137 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 22, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at